LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
News | 02. 08. 2012
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.